Principaux concurrents
Rendement du dividende (Y) Rendement du dividende (Y+1) PER (Y) Price to Book (Y) VE / CA (Y) VE / EBITDA (Y) VE / EBIT (Y) Capi.($)
- - - - - - - 287 M
0,63%0,71%16.17x1.88x3.5x9.45x10.36x 63,56 Md
0,57%0,58%27.72x4.18x5.64x16.51x20.56x 55,92 Md
-.--%-.--%34.62x6.95x11.72x22.19x26.07x 41,68 Md
3,49%3,58%-43.96x2.4x3.12x9.21x10.74x 39,12 Md
-.--%-.--%33.87x1.67x3.61x11.1x12.92x 30,97 Md
-.--%-.--%-8.4x4.92x12.02x-7.38x-6.98x 28,77 Md
-.--%-.--%16.52x3.31x3.14x9.5x9.41x 22,74 Md
-.--%0,06%50.1x5.07x5.51x37.82x35.26x 17,64 Md
-.--%-.--%25.89x3.69x5.38x14.42x19.99x 16,66 Md
-.--%-.--%-34.25x-5.94x15.91x-48.37x-50.28x 14,6 Md
-.--%-.--%-122.1x12746.82x12.46x-110.35x-121.25x 12,38 Md
0,14%0,15%65.5x26.71x39.84x56.35x58.12x 12,37 Md
-.--%-.--%16.42x - 3.51x12.87x15.43x 11,18 Md
-.--%-.--%48.19x - - - - 10,95 Md
2,86%3,31%11.73x1.02x1.79x7.24x9.7x 6,11 Md
1,68%1,86%13.36x1.23x2.3x6.03x7.2x 5,38 Md
-.--%-.--%-107.56x - - - - 5,27 Md
Moyenne 0,55% 0,6% 2,58x 914,56x 8,63x 3,11x 3,82x 21,98 Md
Moyenne pondérée par Capi. 0,6% 0,63% 9,83x 432,95x 7,40x 7,67x 9,07x
Biopharmacies